The Translational Health Sciences (THS) employs a double-blind peer review process to uphold the integrity and quality of each publication. After an initial screening by the Editor-in-Chief to ensure that submissions align with the journal’s scope and standards, manuscripts are assigned to an Editor with relevant expertise. The Editor invites two independent reviewers to evaluate the submission based on specific criteria, including scientific rigor, methodological soundness, originality, and relevance to translational healthcare.

THS aims to provide initial decisions within 2–4 weeks, and authors are encouraged to respond to reviewer comments within a specified timeframe. Authors may appeal editorial decisions by submitting a detailed response outlining their reasons, ensuring transparency and fairness in the review process. THS values the contributions of our reviewers and acknowledges their efforts annually to promote a culture of collaboration and academic rigor. Our structured review process is designed to provide authors with constructive feedback while maintaining the highest standards of scholarly excellence.